Echo Street Capital Management LLC United Therapeutics Corp Transaction History

Echo Street Capital Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$211.82 - $248.24 $267,740 - $313,775	1,264 New	1,264 $285,000
Q1 2023 May 12, 2023	BUY	$212.99 - $276.17 $1.01 Million - $1.31 Million	4,740 New	4,740 $1.06 Million
Q3 2022 Nov 14, 2022	BUY	$203.3 - $244.17 $529,393 - $635,818	2,604 New	2,604 $545,000
Q2 2022 Aug 15, 2022	SELL	$174.81 - $241.14 $900,096 - $1.24 Million	-5,149 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$166.16 - $213.96 $855,557 - $1.1 Million	5,149 New	5,149 $924,000
Q4 2021 Feb 14, 2022	SELL	$184.32 - $216.08 $1.41 Million - $1.66 Million	-7,672 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$179.86 - $214.88 $244,249 - $291,807	1,358 Added 21.51%	7,672 $1.42 Million
Q2 2021 Aug 16, 2021	BUY	$170.47 - $211.93 $1.08 Million - $1.34 Million	6,314 New	6,314 $1.13 Million
Q1 2021 May 17, 2021	SELL	$153.94 - $174.85 $541,560 - $615,122	-3,518 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$101.87 - $151.79 $358,378 - $533,997	3,518 New	3,518 $534,000
Q3 2020 Nov 16, 2020	SELL	$99.9 - $121.13 $577,222 - $699,889	-5,778 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$92.74 - $125.82 $535,851 - $726,987	5,778 New	5,778 $699,000

679

42.1M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.9B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Echo Street Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Echo Street Capital Management LLC with notifications on news.